ScholarIQanswers from OpenAlex

Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist

PaperCitations, authors & open-access status

Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist have?

ScholarIQcitation count

Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist has 332 citations in the OpenAlex counts ScholarIQ stores.

When was Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist published?

ScholarIQyear

Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist has 2004 year in the ScholarIQ index.

What is the open-access status of Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist?

ScholarIQoa status

Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist has green oa status in the ScholarIQ index.

What is the DOI of Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist?

ScholarIQdoi

The DOI for Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist is on the source record.

What is the PMID of Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist?

ScholarIQpmid

The PMID for Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist is on the source record.

What is the OpenAlex record for Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist?

ScholarIQopenalex

The OpenAlex for Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT<sub>2</sub> Receptor Agonist is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial